A low-dose aspirin regimen appears to be safe but does not seem to help Barrett's esophagus patients achieve full remission of dysplasia and intestinal metaplasia following radiofrequency ablation, researchers reported at the American College of Gastroenterology Annual Scientific Meeting. The retrospective analysis from researchers at the Mayo Clinic in Rochester, Minn., included 162 patients diagnosed with Barrett's esophagus with high-grade dysplasia/intramucosal adenocarcinoma.

Related Summaries